Urology Care Foundation Announces 2025 Research Awards of Distinction
The awards acknowledge outstanding contributions to urological research, specifically in pediatrics and prostate cancer. They recognize the accomplishments of previous Urology Care Foundation grant recipients, celebrate the dedication of exemplary research mentors and highlight the efforts of talented early-career scholars.
'We're extremely proud to recognize the extraordinary contributions of this year's awardees,' said Harris M. Nagler, MD, Urology Care Foundation president. 'Their commitment to advancing urologic research to improve urological care is exemplary. The support of dedicated researchers is central to the Foundation's mission.'
Congratulations to this year's recipients:
John W. Duckett, Jr., MD Pediatric Urology Research Excellence Award
Andrew J. Kirsch, MD, clinical professor and chief of Pediatric Urology, Emory University School of Medicine
Established in 2009, the Duckett Award is named in honor of the late world-renowned pediatric urologist and professor and made possible through a fund established by Mrs. Peggy Duckett-Drach and the Societies for Pediatric Urology. The Duckett Award is presented annually to recognize outstanding work in the field of pediatric urology research.
Richard D. Williams, MD Prostate Cancer Research Excellence Award
Howard Scher, MD, head of Biomarker Development Program, Memorial Sloan Kettering Cancer Center and professor of medicine, Weill Cornell Medical College
Established in 2013, the Williams Award is named in honor of the late urologist, scientist, mentor and humanitarian. It's made possible through a fund established by Mrs. Beverly Williams. The Williams Award is presented annually to recognize outstanding and impactful research in the field of prostate cancer over the previous 10 years.
Distinguished Mentor Award
John L. Gore, MD, MS, professor, Department of Urology at University of Washington Medical Center, Fred Hutchinson Cancer Center
Established in 2003, the Distinguished Mentor Award recognizes researchers and physician-scientists who have an outstanding track record of fostering the next generation of research by continually providing an excellent training environment and guidance to early-career investigators.
Distinguished Scholar Alumnus Award
Robert Uzzo, MD, MBA, FACS, president and CEO, Fox Chase Cancer Center
Established in 2003, the Distinguished Scholar Alumnus Award recognizes former Urology Care Foundation Research Scholars who have achieved substantial impactful research and demonstrate an unwavering commitment to scholarship and academic leadership in the field.
Outstanding Graduate Scholar Award
Established in 2016, the Outstanding Graduate Scholar Award recognizes a one-year and two-year Research Scholar Award recipient completing their Urology Care Foundation-funded research. Awardees are chosen based on the quality and difficulty of the applicant's project, the potential impact of their studies, demonstrated research productivity, publications generated during the award period and the scholars' potential as future research leaders. Recipients of this award undergo a competitive application process and are selected by the AUA Research Council and Committees.
Venkat Ramakrishnan, MD, PhD, clinical fellow of Pediatric Urology at Boston Children's Hospital, Harvard Medical School and the Massachusetts Institute of Technology, has received a 2025 Outstanding Graduate Scholar Award for a one-year research project on the Development of a Novel Minimally Invasive Intravesical Drug-Delivery Platform to Address Neurogenic Bladder. It was conducted under the mentorship of Rosalyn Adam, PhD, Boston Children's Hospital, Harvard Medical School.
Asmaa El-Kenawi, PhD, assistant professor of Urology, Indiana University School of Medicine, Department of Urology, and Indiana University Melvin and Bren Simon Comprehensive Cancer Center, has received a 2025 Outstanding Graduate Scholar Award for a two-year research project on Identifying Immune Tumor Cell Metabolic Dependencies in Prostate Cancer. It was conducted under the mentorship of Kosj Yamoah, MD, PhD, Moffitt Cancer Center, Tampa, FL, and Michael Koch, MD, Indiana University School of Medicine Department of Urology.
'I'm inspired by the groundbreaking research being conducted by this year's awardees. Their innovative studies in pediatric urology and prostate cancer advance our scientific understanding and pave the way for significant improvements in patient care,' added Steven Kaplan, MD, chair of the AUA's Research Council. 'Their commitment to pushing the boundaries of urologic research heralds a bright future for our specialty and sets a new standard for clinical excellence.'
The awardees will be celebrated at the Urology Care Foundation Research Honors Program held at the AUA Annual Meeting in April 2025. To learn more, visit AUAnet.org/researchhonors.
About the Urology Care Foundation: The Urology Care Foundation is the world's leading nonprofit urological health foundation, and the official foundation of the American Urological Association. Collaborating with physicians, researchers, patients and the public, the Foundation supports and improves urologic clinical care by funding research, developing patient education and pursuing philanthropic support. To learn more about the Urology Care Foundation and its programs visit: UrologyHealth.org.
About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology, and has more than 25,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy. www.AUAnet.org
Attachment
Corey Del Bianco Urology Care Foundation 443-689-4033 [email protected]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
3 hours ago
- Business Upturn
Mental Health Counselor Online: Felician University's MACP Program Prepares Graduates for a Rewarding Career in Counseling
Rutherford, July 30, 2025 (GLOBE NEWSWIRE) — Competitively priced, Felician University's online MACP program offers an evidence-based, streamlined path to prepare graduates for licensure in mental health counseling. With heightened public awareness around mental health, the industry is experiencing rapid growth of high-demand careers. To help meet the increasing demand for qualified professionals, Felician University offers a comprehensive online Master of Arts in Counseling Psychology (MACP) program designed to prepare students for fulfilling careers in mental health counseling. According to the U.S. Bureau of Labor Statistics, employment for mental health counselors is projected to grow 18% by 2032, which is significantly faster than the average for all occupations. Felician University's program equips graduates to meet this demand in clinical, community, and private practice settings. For individuals seeking a rewarding career in mental health counseling, the online MACP equips aspiring professionals with the skills to address diverse mental health challenges. Offering a pathway to licensure, the program enables students to balance education with personal and professional commitments, making it an ideal choice for career changers or those advancing in the field. Meeting the standards of the Masters in Psychology and Counseling Accreditation Council (MPCAC) for science-based counseling education, the MACP program is a flexible, high-quality education program for working adults. With the MACP coursework aligned to national certification requirements, graduates are well-placed to pursue their careers as Licensed Professional Counselors in New Jersey and other states. Felician University prioritizes personalized mentorship and small class sizes, cultivating strong connections between students and faculty. Through field placement support and hands-on experiences, students are equipped to translate classroom knowledge into real-world University's online counseling psychology program applies a community-focused curriculum, preparing the next generation of practitioners with the requisite skills and knowledge needed to become licensed professional counselors. Essential for today's mental health professionals, the curriculum emphasizes evidence-based practices, trauma-informed care, and multicultural competency. As the need for qualified mental health counselors continues to rise, the online MACP program integrates ethical practice and social justice principles, ensuring graduates can effectively serve underserved populations. For more information, visit Felician University has been a notable leader in student-centered education for over 75 years. Rooted in Franciscan values, it provides academic excellence with the flexibility needed for the new generation of learners. As an MPCAC-aligned program, the online Master of Arts in Counseling Psychology is recognized for its quality and shared value, ensuring graduates can launch their careers as counselors in just over two years. With three intakes annually, this program can be completed full-time (over seven semesters) or part-time (10 semesters), covering 60 credit hours, 100 practicum hours, and over 600 internship hours. The Felician University online MACP program blends holistic care, positive psychology, and Franciscan values, empowering students to understand the full spectrum of human behavior, from personal challenges to complex mental health issues. The MACP also offers students a unique opportunity with its forensic track, designed to prepare graduates for impactful counseling careers working specifically with offenders or victims in the justice system. They will learn the skills needed to thrive in various settings, including victim services, correctional facilities, juvenile detention centers, probation and parole agencies, and social service organizations. Felician University prepares students to address the growing need for counseling professionals, helping them pursue licensure and excel in roles such as mental health counselors. The online Master of Arts in Counseling Psychology program reflects its commitment to enabling accessible education for career-focused learners, empowering future graduates to serve with compassion and social justice. About the University: Felician University, a private Franciscan institution in Rutherford, New Jersey, offers a comprehensive Master of Arts in Counseling Psychology program. Designed for aspiring mental health counselors, the flexible online format combines rigorous academics with hands-on clinical training. The MPCAC-aligned curriculum emphasizes trauma-informed care, ethics, and cultural competence, ensuring graduates meet licensure requirements. ### For more information about Felician University, contact the company here: Felician UniversityFelician University [email protected] One Felician Way, Rutherford, New Jersey, 07070
Hamilton Spectator
10 hours ago
- Hamilton Spectator
Novasight™ Hybrid Imaging System Featured in Published JSCAI Case Report Demonstrating Superior Diagnosis and Precision-Guided Therapy in Complex Coronary Case
TORONTO, July 30, 2025 (GLOBE NEWSWIRE) — Conavi Medical Inc. (TSXV: CNVI) (OTCQB: CNVIF), a leader in hybrid intravascular imaging, is pleased to announce the publication of a compelling case report in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI) highlighting the clinical impact of the Company's Novasight™ Hybrid IVUS-OCT System in guiding accurate diagnosis and optimal stent placement in a complex coronary artery case. The case was performed, and the images were collected using the first-generation Novasight Hybrid IVUS-OCT system. 'This publication validates our belief that hybrid imaging is the future of precision-guided interventional cardiology,' said Thomas Looby, CEO of Conavi Medical. 'Our goal is to help physicians make faster, more accurate decisions and ultimately improve patient outcomes. Also, this article is based on the first-generation system. We are especially excited about our next-generation Novasight™ Hybrid System, which is designed to deliver enhanced image quality and functionality for even greater physician and patient benefit, and the U.S. FDA 510(k) submission is on track for Q3 2025.' The report, titled 'The Role of Comprehensive Hybrid Imaging in Identification of Plaque Rupture and Ostial Stent Placement: Case Report' (DOI: 10.1016/ details the treatment of a 52-year-old male patient with multiple cardiovascular risk factors, including diabetes, hypertension, hyperlipidemia, and end-stage renal disease. Initial angiography suggested a calcified lesion at the ostium of the right coronary artery (RCA). However, hybrid imaging using the Novasight™ System, integrating both intravascular ultrasound (IVUS) and optical coherence tomography (OCT), revealed the true culprit: a plaque rupture, not significant calcification. 'Hybrid imaging has the power to transform how we diagnose and treat complex coronary disease,' said Dr. Megha Prasad, co-author of the study and interventional cardiologist. 'In this patient, angiography alone could have potentially led us down the wrong path. The ability to combine the high-resolution structural detail of OCT with the anatomical reference points of IVUS in real time allowed us to correctly identify the plaque rupture and precisely treat the lesion, something neither modality could have done alone.' The case demonstrates how the simultaneous use of intravascular ultrasound (IVUS) and optical coherence tomography (OCT) via the Novasight Hybrid catheter enabled physicians to: The publication reinforces the Novasight™ System's role in aligning with new U.S. imaging Class 1A Guidelines for intracoronary imaging and Acute Coronary Syndrome (ACS) that advocate for broader use of intracoronary imaging in PCI. Conavi's hybrid solution uniquely addresses long-standing barriers to adoption, including the need for separate imaging systems and interpretation challenges, particularly among less experienced operators. Figure 1: Before percutaneous coronary intervention (A) Angiogram of right coronary artery (RCA) lesion; intravenous ultrasound (top) and optical coherence tomography (bottom) visualizations of (B) ostial RCA, (C) conus branch, (D) intraplaque hemorrhage and wire artifact, (E) plaque rupture cavity and wire artifact, and (F) distal reference Figure 2: After percutaneous coronary intervention (A) Angiogram of right coronary artery (RCA) lesion; intravenous ultrasound (top) and optical coherence tomography (bottom) visualizations of (B) proximal edge of stent struts of ostial RCA (demonstrating no extension into the aorta), (C) minimal stent area of 9.40 mm 2 , (D) distal stent edge struts and wire artifact, and (E) the distal reference. About Conavi Medical Corp.: Conavi Medical is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its patented Novasight Hybrid™ System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. The Novasight Hybrid System has 510(k) clearance from the U.S. Food and Drug Administration; and regulatory approval for clinical use from Health Canada, China's National Medical Products Administration, and Japan's Ministry of Health, Labor and Welfare. For more information, visit . Cautionary Statement Regarding Forward-Looking Information This news release contains 'forward-looking statements' within the meaning of applicable Canadian and U.S. securities laws, which reflect the current expectations of management of Conavi's future growth, results of operations, performance and business prospects and opportunities. Forward-looking statements are frequently, but not always, identified by words such as 'may', 'would', 'could', 'will', 'anticipate', 'believe', 'plan', 'expect', 'intend', 'estimate', 'potential for' and similar expressions, although these words may not be present in all forward-looking statements. Forward-looking statements that appear in this release may include, without limitation, references to Conavi's plans for the commercialization of its Novasight Hybrid™ System. These forward-looking statements reflect management's current beliefs with respect to future events, and are based on information currently available to management that, while considered reasonable by management as of the date on which the statements are made, are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in actions, events, conditions, results, performance or achievements to be materially different from those projected in the forward-looking statements. Forward-looking statements involve significant risks, uncertainties and assumptions and many factors could cause Conavi's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements. Such factors and assumptions include, but are not limited to, Conavi's ability to retain key personnel; its ability to execute on its business plans and strategies; and other factors listed in the 'Risk Factors' sections of the joint information circular of Conavi dated August 30, 2024 and in the final short form prospectus of Conavi dated April 15, 2025 (each of which may be viewed at ). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance, or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions and Conavi has attempted to identify important factors that could cause actual actions, events, conditions, results, performance or achievements to differ materially from those described in forward-looking statements, Conavi cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. Except as required by law, Conavi expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. Accordingly, investors should not place undue reliance on forward-looking statements. All the forward-looking statements are expressly qualified by the foregoing cautionary statements. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release. Contact Stefano Picone Chief Financial Officer (416) 483-0100 Photos accompanying this announcement are available at
Hamilton Spectator
12 hours ago
- Hamilton Spectator
KFSHRC Advances Robotic Surgery with a Successful Ivor Lewis Esophagectomy
RIYADH, Saudi Arabia, July 30, 2025 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh successfully performed a robotic Ivor Lewis esophagectomy, the first of its kind in the Middle East, on a 46-year-old male diagnosed with gastroesophageal junction adenocarcinoma, a type of cancer located near the area where the esophagus meets the stomach. The patient regained mobility within two days of surgery, began oral intake by day five, and was discharged within ten days. This outcome demonstrates the effectiveness of the robotic approach in reducing pain, minimizing complications, and accelerating recovery compared to conventional surgery. The procedure was led by Dr. Khalid Aldaghri, Consultant in bariatric, upper gastrointestinal, and robotic surgery at KFSHRC. Utilizing the Ivor Lewis technique, a complex and technically demanding procedure involving two phases. The abdominal phase involved stomach mobilization and creation of a gastric conduit. This was followed by the thoracic phase, in which the diseased esophagus was resected and the conduit is robotically connected within the chest. Precision in the robotic system enabled surgeons to reach deep anatomical areas without large incisions, enhancing safety, reducing risks, and improving outcomes in one of the most complex cancer surgeries. Close collaboration among surgical, anesthesia, nursing, and technical teams was key to the procedure's success. All teams worked synchronously across every stage, from pre-op planning to post-op recovery. This approach reflects KFSHRC's multidisciplinary model of care, designed to improve patient outcomes and boost clinical efficiency. With its advanced features, the robotic surgery significantly enhanced the safety and accuracy of the esophagectomy by offering three-dimensional high-definition visualization, stable instrument control, and superior access within confined anatomical spaces. These capabilities enabled more precise dissection, better preservation of surrounding structures such as nerves and vessels and reduced intraoperative risks. The technology also made it physically easier for the surgeon to operate over an extended period. As a medical milestone, the success of this procedure opens the door for broader applications of robotic surgery at KFSHRC. It enables more patients to benefit from advanced surgical techniques and reinforces the institution's commitment to clinical innovation, safety, and effective alternatives to traditional surgical approaches. It is noteworthy that KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. For more information, visit or contact our media team at mediacoverage@ A photo accompanying this announcement is available at
